SEMDEXA (TM) (SP-102) is a trademark owned by Semnur Pharmaceuticals, Inc., a majority-owned subsidiary of Scilex Holding Company. A proprietary name review by the FDA is planned. ZTlido (R) is a ...
Val Van Brocklin writes regularly about the interaction of Alaska’s mental health and justice systems and the impact on ...
Phase III OASIS 4 trial showed 16.6% mean weight loss with oral semaglutide, outperforming placebo. The FDA approval of oral semaglutide marks the first GLP-1 pill for chronic weight management, ...
The U.S. Food and Drug Administration on Dec. 22 approved a pill version of Novo Nordisk’s weight-loss drug Wegovy.
Lakeville Professional Assists Diabetic Patient Avoid Foot Amputation And Improves Neuropathy Symptoms Lakeville, United States – December 19, 2025 / ALIGN Integrated Health / Lakeville, MN – A ...
Manulife Hong Kong today announced an expansion of its partnership with Hong Kong Baptist Hospital (HKBH) through the launch ...
Firmonertinib has the potential to redefine first-line treatment in this underserved population as a once daily, oral, brain-penetrant, chemo-free monotherapyALPACCA pivotal trial is designed to ...
Jeffrey Epstein appeared to make a dark joke about suicide in a letter to disgraced USA Gymnastics coach Larry Nassar — which ...
Eli Lilly hiked its revenue growth guidance by 7%, while Novo Nordisk was forced to slash its targets by ~12%. See why I'm ...
4don MSN
‘A challenging 4 months’: Billy Porter shares health update after being hospitalized with sepsis
Tony Award winner Billy Porter is giving fans an update after he was forced to leave a Broadway play due to a "challenging" ...
DehydraTECH-semaglutide reduced overall side effects by 48% as compared to Rybelsus® DehydraTECH-semaglutide reduced gastrointestinal side effects by 55% as compared to Rybelsus® Recent financings ...
The Colorado Department of Corrections can house about 15,077 men across state and privately run prisons. The male population ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results